Seeking Alpha

Allergan (AGN -1.8%) stumbles midday as RBC says Caremark has removed Lumigan from its 2013...

Allergan (AGN -1.8%) stumbles midday as RBC says Caremark has removed Lumigan from its 2013 formulary coverage. RBC sees a $0.15 hit to AGN's 2013 EPS (company earned $0.74 in 2012 Q1).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|